CD8A and neoplasm: However, those mice showed an increased CD8+ T-cell tumor infiltration associated with increased IFN-γ, IL-17 and PD-1 expression, suggesting that PI3Kγ inhibition could synergize with immunotherapies targeting PD-L1 in this cancer [70].